Research institute for biological safety problems
Congratulations to the chief researcher of the laboratory “Collection of Microorganisms”, Candidate of Veterinary Sciences, Associate Professor Muratbay Mambetaliev with the assignment of the academic title “PROFESSOR” in the specialty…
RIBSP scientists knew about the Tengrinews.kz journalist’s participation Aynash Ondiris in the article of media “180 days in the experiment: How I participated in the phase III clinical trial of…
On this significant day, RIBSP congratulates all journalists who covered the progress of scientific development, preclinical and clinical studies, as well as the production of the first domestic vaccine against…
On June 23, 2021, the Department for Registration and Land Cadastre of the branch of the non-profit joint-stock company «State Corporation «Government for Citizens» for the Zhambyl region» of the…
On June 22, 2021, Kazakhstan’s second COVID-19 vaccine QazCoVac-P (subunit) was officially included in the list of candidate vaccines of the World Health Organization for conducting phase 1/2 clinical trials.…
On June 19, 2021, in Nur-Sultan, an award ceremony for the best doctors of Kazakhstan, the winners of the competition “Our dear doctor! Our Hero!”, dedicated to the Day of…
On the day of the medical worker, the Minister of Health of the Republic of Kazakhstan Alexey Vladimirovich Tsoi presented a departmental award: a badge “For contribution to healthcare” to…
On June 15, 2021, clinical studies of COVID-19 domestic subunit vaccine with the involvement of volunteers from 18 to 50 years old in Taraz city multi-field hospital have begun. RSE…
On May 28, 2021, the Chairwoman of the World Health Organization (WHO) in Kazakhstan, Caroline Clarinval, met with the Director General of the Research Institute for Biological Safety Problems. During…
President of the Republic of Kazakhstan Kassym-Jomart Tokayev held a meeting with Director-General of the World Health Organization Dr. Tedros Adhanom Ghebreyesus via videoconference. During the talks, the sides discussed…